Report

MCMi Program Update Fiscal Year 2017

The U.S. Food and Drug Administration (FDA) plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. The FDA ensures that medical countermeasures for these threats are safe, effective, and secure. This annual report details the FDA’s medical countermeasure activities for fiscal year (FY) 2017 (1 October 2016–30 September 2017).

https://www.fda.gov/downloads/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/UCM603540.pdf

SHARE:

TAGS:

COMMENTS

Report

MCMi Program Update Fiscal Year 2017

The U.S. Food and Drug Administration (FDA) plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. The FDA ensures that medical countermeasures for these threats are safe, effective, and secure. This annual report details the FDA’s medical countermeasure activities for fiscal year (FY) 2017 (1 October 2016–30 September 2017).

https://www.fda.gov/downloads/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/UCM603540.pdf

SHARE:

TAGS:

COMMENTS

Translate »